Ab Corporate Bond Etf Cash And Equivalents
| EYEG Etf | USD 34.87 0.06 0.17% |
AB Corporate Bond fundamentals help investors to digest information that contributes to AB Corporate's financial success or failures. It also enables traders to predict the movement of EYEG Etf. The fundamental analysis module provides a way to measure AB Corporate's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AB Corporate etf.
EYEG |
AB Corporate Bond ETF Cash And Equivalents Analysis
AB Corporate's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current AB Corporate Cash And Equivalents | 3.66 M |
Most of AB Corporate's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AB Corporate Bond is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, AB Corporate Bond has 3.66 M in Cash And Equivalents. This is much higher than that of the Healthcare family and significantly higher than that of the Corporate Bond category. The cash and equivalents for all United States etfs is notably lower than that of the firm.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
EYEG Fundamentals
| Return On Equity | -103.8 | |||
| Return On Asset | -40.35 | |||
| Current Valuation | 18.1 M | |||
| Shares Outstanding | 7.1 M | |||
| Shares Owned By Insiders | 12.18 % | |||
| Shares Owned By Institutions | 24.20 % | |||
| Number Of Shares Shorted | 54.54 K | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 1.55 X | |||
| Revenue | 12.06 K | |||
| Gross Profit | (3.55 M) | |||
| EBITDA | (9.34 M) | |||
| Net Income | (9.47 M) | |||
| Cash And Equivalents | 3.66 M | |||
| Cash Per Share | 0.29 X | |||
| Total Debt | 308.01 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.07 X | |||
| Book Value Per Share | 1.26 X | |||
| Cash Flow From Operations | (8.66 M) | |||
| Short Ratio | 0.02 X | |||
| Earnings Per Share | (1.77) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.8 | |||
| Market Capitalization | 13.84 M | |||
| Total Asset | 10.62 M | |||
| Retained Earnings | (108.16 M) | |||
| Working Capital | 102 K | |||
| Current Asset | 6.26 M | |||
| Current Liabilities | 6.16 M | |||
| One Year Return | 5.90 % |
About AB Corporate Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AB Corporate Bond's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AB Corporate using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AB Corporate Bond based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out AB Corporate Piotroski F Score and AB Corporate Altman Z Score analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
The market value of AB Corporate Bond is measured differently than its book value, which is the value of EYEG that is recorded on the company's balance sheet. Investors also form their own opinion of AB Corporate's value that differs from its market value or its book value, called intrinsic value, which is AB Corporate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AB Corporate's market value can be influenced by many factors that don't directly affect AB Corporate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AB Corporate's value and its price as these two are different measures arrived at by different means. Investors typically determine if AB Corporate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AB Corporate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.